Skip to main content
OpenTrials
Completed

NCT Number: NCT02856633

Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station

The study objective is to satisfy the testing requirements for the Qualcomm Tricorder XPRIZE Competition. This requires an oversight model using the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station to continuously monitor the patient's five core vital signs and to detect the health conditions required by the competition.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 65 years of age.
  • English speaking
  • Established diagnosis of one of the thirteen required conditions with evidence in Medical Record.

Exclusion criteria

  • Lack of patient consent
  • Has pacemaker or internal medical device
  • Pregnancy
  • Concurrent enrollment into a clinical trial that may affect subject treatment
  • Age less than 18 or over 65
  • Physical disabilities affecting vision (eyeglasses or contact lenses will be allowed), manual manipulation, or use of a computer or mobile device

Treatment and study plan

Vitaliti

Device

Primary outcomes

  1. Successful diagnosis of patient's condition by Vitaliti software as compared to patient's Medical Record

    Time frame: 90 minutes

Sponsors and collaborators

Lead sponsor

Cloud DX Inc.

Industry

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Aug 5, 2016
Registry last updated
May 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.